Interstitial and orphan lung disease

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
Vissagan Gopalakrishnan, Amanda M. Jones, Patricia Julien-Williams, Tania Machado, Robert L. Danner, Jeffrey J. Swigris, Robert Paine, Jay N. Lozier, Joel Moss

ERJ Open Research Jan 2018, 4 (1) 00121-2017; DOI: 10.1183/23120541.00121-2017
Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis
Mouhamad Nasser, Julie Traclet, Vincent Cottin

ERJ Open Research Jan 2018, 4 (1) 00089-2017; DOI: 10.1183/23120541.00089-2017
An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis
Evans R. Fernández Pérez, Pearlanne Zelarney, Shirley Thomas, Deborah A. Shoop, Jessica L. Munson, Kelsey D. Johnson, Matthew E. Stern, Sarah Meadows

ERJ Open Research Jan 2018, 4 (1) 00093-2017; DOI: 10.1183/23120541.00093-2017
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis
Eisuke Kato, Noboru Takayanagi, Yotaro Takaku, Naho Kagiyama, Tetsu Kanauchi, Takashi Ishiguro, Yutaka Sugita

ERJ Open Research Jan 2018, 4 (1) 00111-2016; DOI: 10.1183/23120541.00111-2016
The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases
Huan Bian, Xiaowei Nie, Xin Bu, Feng Tian, Libo Yao, Jingyu Chen, Jin Su

ERJ Open Research Jan 2018, 4 (1) 00138-2016; DOI: 10.1183/23120541.00138-2016
Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
Caroline E. Wright, Simon D. Fraser, Kayleigh Brindle, Alyn H. Morice, Simon P. Hart, Michael G. Crooks

ERJ Open Research Oct 2017, 3 (4) 00100-2017; DOI: 10.1183/23120541.00100-2017
mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
Kaisa Rajala, Juho T. Lehto, Eva Sutinen, Hannu Kautiainen, Marjukka Myllärniemi, Tiina Saarto

ERJ Open Research Oct 2017, 3 (4) 00084-2017; DOI: 10.1183/23120541.00084-2017
Towards a global initiative for fibrosis treatment (GIFT)
Maria Molina-Molina, Alvar Agusti, Bruno Crestani, David A. Schwartz, Melanie Königshoff, Rachel C. Chambers, Toby M. Maher, Rosa Faner, Ana Lucia Mora, Mauricio Rojas, Katerina M. Antoniou, Jacobo Sellares

ERJ Open Research Oct 2017, 3 (4) 00106-2017; DOI: 10.1183/23120541.00106-2017
Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis
Akihiko Sokai, Kiminobu Tanizawa, Tomohiro Handa, Kumiko Kanatani, Takeshi Kubo, Kohei Ikezoe, Yoshinari Nakatsuka, Shinsaku Tokuda, Toru Oga, Toyohiro Hirai, Sonoko Nagai, Kazuo Chin, Michiaki Mishima

ERJ Open Research Jul 2017, 3 (3) 00019-2016; DOI: 10.1183/23120541.00019-2016
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Ayodeji Adegunsoye, Justin M. Oldham, Evans R. Fernández Pérez, Mark Hamblin, Nina Patel, Mitchell Tener, Deepa Bhanot, Lacey Robinson, Sam Bullick, Lena Chen, Scully Hsu, Matthew Churpek, Donald Hedeker, Steven Montner, Jonathan H. Chung, Aliya N. Husain, Imre Noth, Mary E. Strek, Rekha Vij

ERJ Open Research Jul 2017, 3 (3) 00016-2017; DOI: 10.1183/23120541.00016-2017

Main menu

User menu

Search

Interstitial and orphan lung disease

Pages

Contact us